Director/PDMR Shareholding


Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4

On 3 January 2016, Pascal Soriot, a Director of the Company, notified us that,
on 31 December 2015, he ceased to be beneficially interested in 250,100
AstraZeneca PLC Ordinary Shares of $0.25 each as a result of a gift of those
shares to family members for nil consideration.

A C N Kemp
Company Secretary
4 January 2016

Attachments

01041471.pdf